![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Leukemia |
|
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Leukemia is free of charge.
Bytes to Blood-Artificial Intelligence in the Management of Leukemia: A 2025
Update.
Am J Clin Oncol. 2026 Mar 4. doi: 10.1097/COC.0000000000001315.
PubMed
Abstract available
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for
Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.
Am J Hematol. 2026 Mar 2. doi: 10.1002/ajh.70265.
PubMed
Abstract available
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for
relapsed/refractory acute myeloid leukemia.
Blood. 2026 Mar 3:blood.2025032299. doi: 10.1182/blood.2025032299.
PubMed
Abstract available
Two new options for NPM1-mutated relapsed, refractory acute myeloid leukemia:
Researchers are looking into whether revumenib or ziftomenib can be combined with
first-line standard-of-care treatment options.
Cancer. 2026;132:e70275.
PubMed
Updating Efficacy of First-Line Treatments for Chronic Lymphocytic Leukemia:
Indirect Comparisons Based on Recent Data Favor the Combination of Acalabrutinib
Plus Obinutuzumab.
Eur J Haematol. 2026 Mar 2. doi: 10.1111/ejh.70150.
PubMed
Chaperone-assisted expression and purification of the AML-associated Src-family
kinase Fgr in Escherichia coli.
J Biol Chem. 2026;302:111099.
PubMed
Abstract available
Dynamic and extensive A-to-I RNA recoding in immunoglobulin shapes myeloid
neoplasm transcriptome.
J Biol Chem. 2026;302:111066.
PubMed
Abstract available
Measurable residual disease detection in acute leukemia: Technological advances
and clinical translation.
Leuk Res. 2026;163:108197.
PubMed
Abstract available
Correction: Regulation of metabolic adaptation and leukemia progression by
MUSASHI2-DEPTOR-KIF11 axis.
Leukemia. 2026 Mar 5. doi: 10.1038/s41375-026-02909.
PubMed
Thank you for your interest in scientific medicine.